Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 15
2003 14
2004 18
2005 20
2006 28
2007 31
2008 34
2009 43
2010 41
2011 64
2012 63
2013 65
2014 73
2015 56
2016 53
2017 52
2018 54
2019 43
2020 57
2021 48
2022 44
2023 43
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

843 results

Results by year

Filters applied: . Clear all
Page 1
Progression of the FIB-4 index among patients with chronic HCV infection and early liver disease.
Krassenburg LAP, Maan R, Puenpatom A, Erler NS, Welsch C, van Hees S, Cerrhoci O, Vermehren J, de Knegt RJ, Hansen BE, Zeuzem S, Vanwolleghem T, Janssen HLA, de Man RA, Feld JJ, van der Meer AJ. Krassenburg LAP, et al. Among authors: zeuzem s. BMJ Open Gastroenterol. 2023 Dec 7;10(1):e001209. doi: 10.1136/bmjgast-2023-001209. BMJ Open Gastroenterol. 2023. PMID: 38637963 Free PMC article.
From the Editor's Desk..
Burra P, Tacke F, Ratziu V, Zeuzem S, Sangro B, Angeli P. Burra P, et al. Among authors: zeuzem s. J Hepatol. 2024 May;80(5):673-675. doi: 10.1016/j.jhep.2024.02.024. J Hepatol. 2024. PMID: 38637103 No abstract available.
From the Editor's Desk..
Burra P, Tacke F, Ratziu V, Zeuzem S, Sangro B, Angeli P. Burra P, et al. Among authors: zeuzem s. J Hepatol. 2024 Apr;80(4):531-533. doi: 10.1016/j.jhep.2024.01.017. J Hepatol. 2024. PMID: 38494309 No abstract available.
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series.
Dietz-Fricke C, Degasperi E, Jachs M, Maasoumy B, Reiter FP, Geier A, Grottenthaler JM, Berg CP, Sprinzl K, Zeuzem S, Gödiker J, Schlevogt B, Herta T, Wiegand J, Soffredini R, Wedemeyer H, Deterding K, Reiberger T, Lampertico P. Dietz-Fricke C, et al. Among authors: zeuzem s. Hepatology. 2024 Mar 13. doi: 10.1097/HEP.0000000000000847. Online ahead of print. Hepatology. 2024. PMID: 38478755
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis.
Mücke MM, Hernández-Tejero M, Gu W, Kuhn M, Janz M, Keller MI, Fullam A, Altepeter L, Mücke VT, Finkelmeier F, Schwarzkopf KM, Cremonese C, Hunyady PM, Heilani MW, Uschner FE, Schierwagen R, Brol MJ, Fischer J, Klein S, Peiffer KH, Hogardt M, Shoaie S, Coenraad MJ, Bojunga J, Arroyo V, Zeuzem S, Kempf VAJ, Welsch C, Laleman W, Bork P, Fernandez J, Trebicka J; MICROB-PREDICT and PREDICT Study Group of the EASL-CLIF Consortium. Mücke MM, et al. Among authors: zeuzem s. Aliment Pharmacol Ther. 2024 Apr;59(7):877-888. doi: 10.1111/apt.17899. Epub 2024 Feb 27. Aliment Pharmacol Ther. 2024. PMID: 38414095
Heterogeneity of small duct- and large duct-type intrahepatic cholangiocarcinoma.
Kinzler MN, Schulze F, Jeroch J, Schmitt C, Ebner S, Gretser S, Bein J, Finkelmeier F, Trojan J, Zeuzem S, Schnitzbauer AA, Demes MC, Reis H, Wild PJ, Walter D. Kinzler MN, et al. Among authors: zeuzem s. Histopathology. 2024 May;84(6):1061-1067. doi: 10.1111/his.15162. Epub 2024 Feb 26. Histopathology. 2024. PMID: 38409827
From the Editor's Desk..
Burra P, Tacke F, Ratziu V, Zeuzem S, Sangro B, Angeli P. Burra P, et al. Among authors: zeuzem s. J Hepatol. 2024 Mar;80(3):381-383. doi: 10.1016/j.jhep.2024.01.001. J Hepatol. 2024. PMID: 38368017 No abstract available.
843 results